Just for information, some nuance seems to have been lost in translation in some of the English language coverage. Nothing critical but if you're wondering about insipid expressions like 'discomfort after effort', that was 'malaise après effort' in the original French, which basically means PEM.
For the purpose of a diagnostic test it probably doesn't matter whether the microRNAs they're measuring reflect PEM or some ME-specific fatiguability, as long as it's ME specific.
But since they're claiming it is PEM it would have made a lot of sense to take another sample at 24 hours, just to be sure. They asked participants about PEM symptoms later and PEM symptoms were indeed reported by pwME but not controls. Fine, but here we're back in questionnaire territory which is what we're trying to get away from with a diagnostic test. And it doesn't tell us if those symptoms were also reflected in microRNA.
Also, looking at the supplementary data, the PEM symptoms reported were largely fatigue (72%), headache and muscle pain (16% each) and only a few reports of other symptoms. This could be interpreted as very mild PEM, something the researchers were aiming for as they wanted their participants to suffer as little as possible, but it could equally be fatiguability rather than PEM.
Jumping ahead of myself here but a clinical diagnostic test that requires a health professional to travel to patients to perform a 90 minute test - just ain't gonna happen most places. Even if there was ready access to the type of lab required to run this sort of analysis. Would still be good to have a research diagnostic test of course, to ensure participants actually have ME, or a certain subgroup of ME.
The differences between the four clusters look interesting but each cluster has only between 5 and 11 people in it. Assuming the results can be replicated on a larger scale, it seems a significant finding that in some clusters microRNAs are upregulated and in others downregulated. Certainly would have the potential to confound research if not taken into account.